Clinical Trial Update: Low-Dose Leptin and the Formerly-Obese [Phase 3]

View source ↗

Summary

This document notes a Phase 3 trial studying low-dose leptin for obesity in formerly obese individuals, sponsored by NIDDK. The current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Leptin (leptin)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Obesity | Phase 3 | Status: UNKNOWN